NCT04650165Completed
10-year Progression of Diabetic Retinopathy: Identification of Signs and Surrogate Outcomes
Source: ClinicalTrials.gov · Last updated 16 Oct 2024
Brief summary (registry, in English)
To characterize both functionally and morphologically initial Diabetic Retinopathy (DR) stages and their progression over a period of 10 years.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 119 (actual)
- First submitted
- 25 Nov 2020
- Start date
- 1 Jun 2021
- Primary completion date
- 27 Mar 2024
- Lead sponsor
- Association for Innovation and Biomedical Research on Light and Image
- Diseases
- Diabetic eye disease
- NCT number
- NCT04650165
What you commit to
- Study type: Observational
- Participants enrolled: 119
- From 1 Jun 2021 to the primary completion date, 27 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \- Inadequate ocular media and/ or pupil dilatation that interfere with fundus examinations
Who the study is looking for
- Subjects who have participated in the PROGRESS study;
- Subjects capable of understanding the information about the study and to give their informed consent to enter the study.
- Subjects willing and able to comply with the study
Age in the registry: 35 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| AIBILI - Association for Innovation and Biomedical Research on Light and Image Coordinator of this site? Confirm its status | Coimbra | Portugal | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.